EAGLE PHARMACEUTICALS, INC. short interest in 2021
In 2021, EAGLE PHARMACEUTICALS, INC.'s disclosed short interest ran from 11.00% of shares outstanding on 15 Jan 2021 to 4.49% on 31 Dec 2021, a change of -6.51 percentage points. The year's high was 11.00% on 15 Jan 2021 and its low 4.49% on 31 Dec 2021, averaging 7.57% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.71 days on 28 May 2021. Full history: EAGLE PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2021 in figures
- Start of year
- 11.00% (15 Jan 2021)
- End of year
- 4.49% (31 Dec 2021)
- Change
- -6.51 pp
- High
- 11.00% (15 Jan 2021)
- Low
- 4.49% (31 Dec 2021)
- Average
- 7.57%
- Highest days to cover
- 14.71 (28 May 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 11.00% | 12.74 | |
| 29 Jan 2021 | 10.73% | 14.25 | |
| 12 Feb 2021 | 9.94% | 12.22 | |
| 26 Feb 2021 | 10.77% | 13.72 | |
| 15 Mar 2021 | 10.76% | 10.55 | results (8-K), 10-K filed |
| 31 Mar 2021 | 10.48% | 13.55 | |
| 15 Apr 2021 | 8.75% | 8.46 | |
| 30 Apr 2021 | 8.08% | 13.83 | |
| 14 May 2021 | 8.25% | 14.59 | 10-Q filed, results (8-K) |
| 28 May 2021 | 8.05% | 14.71 | |
| 15 Jun 2021 | 7.86% | 7.29 | |
| 30 Jun 2021 | 7.29% | 5.45 | |
| 15 Jul 2021 | 7.06% | 7.16 | |
| 30 Jul 2021 | 7.39% | 12.48 | |
| 13 Aug 2021 | 7.03% | 11.58 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 6.56% | 6.85 | |
| 15 Sep 2021 | 6.34% | 7.83 | |
| 30 Sep 2021 | 6.04% | 6.69 | |
| 15 Oct 2021 | 5.35% | 7.44 | |
| 29 Oct 2021 | 5.26% | 9.86 | |
| 15 Nov 2021 | 4.95% | 10.79 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 4.79% | 7.77 | |
| 15 Dec 2021 | 4.53% | 3.83 | |
| 31 Dec 2021 | 4.49% | 4.49 |
See also: EAGLE PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.